查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1429021

全球骨科生物製品市场评估：依产品、应用、最终用户、地区、机会、预测（2017-2031）

Orthobiologics Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 228 Pages | 商品交期: 3-5个工作天内

价格

全球骨科生物製品市场规模预计将从 2023 年的 70.1 亿美元增至 2031 年的 112.4 亿美元，2024-2031 年预测期间复合年增长率为 6.08%。我是。 市场主要由技术进步驱动。 医疗技术的进步，包括生物材料和手术方法的改进，使骨科生物学解决方案得到更广泛的应用。 这项进步使得能够更有效地治疗骨骼和关节问题，使骨科生物製剂的选择对患者和医生都更具吸引力。

由于世界人口老化，全球骨科生物製品市场正在扩大。 人们的寿命越长，就越有可能出现与年龄相关的骨科问题，例如骨质疏鬆症和关节炎。 这种人口结构的变化正在推动对骨科生物学治疗的需求，这些治疗经常用于加速老年人常见的骨折和退化性疾病的癒合过程。

由于所有年龄层（包括年轻人和活跃人群）骨科问题的增加，全球骨科生物製品市场正在成长。 与生活方式选择相关的肌肉骨骼问题和运动相关损伤的增加导致需要骨科生物治疗的患者数量增加。

此外，全球骨科生物製品市场的动态受到对微创手术解决方案日益增长的需求的影响。 骨科生物製剂经常用于微创手术，具有恢復时间更快、感染机会更低和术后疼痛更少等优点。 由于向微创技术的转变，骨生物製剂在外科手术中得到了更广泛的应用，尤其是运动医学外科手术。

例如，Tetrous, Inc. 于 2023 年 7 月宣布，其用于运动医学手术的 Enfix(TM) 脱矿骨纤维植入物已获得美国专利。 EnFix RC 是 EnFix 系列中的首款产品，是专为肩袖修復手术设计的植入物。 目前，EnFix RC 仅在澳洲和美国销售。

骨科疾病激增推动市场发展

由于全球骨科疾病盛行率不断上升，全球骨科生物製品市场正在快速成长。 越来越多的人患有骨质疏鬆症、关节炎和脊椎疾病等疾病，这增加了对有效治疗解决方案的需求。 促进骨修復和再生的骨生物製剂对于治疗这些疾病至关重要。 现代生活方式带来的肌肉骨骼问题和运动伤害的增加进一步加剧了对这些治疗的需求。 由于健康问题日益严重，市场不断扩大，这推动了研究和开发，为各种骨科问题创造更精细、更有效的解决方案。

根据《刺胳针风湿病学》最近发表的一项研究，关节、肌肉和骨骼问题在未来 30 年内将增加 115%。 到2050年，全球将有超过10亿人受到肌肉、骨骼、关节、韧带、肌腱和脊椎疾病的影响。 COVID-19 大流行的影响可能在这些预测中发挥重要作用。

科技进步推动市场发展

技术进步在全球骨科生物製品市场的成长中发挥重要作用，特别是以新的、更有效的产品和治疗的形式。 随着生物材料和生物疗法的进步，骨骼和关节问题的治疗变得越来越成功。 例如，组织工程和再生医学的进步提高了骨科手术所必需的支架和骨移植物的品质。 3D 列印技术的进步也允许客製化骨科设备和植入物，以满足个别患者的需求。 除了改善患者的治疗效果外，这些技术进步还将扩大可治疗的疾病范围并扩大全球骨科生物製品市场。

本报告研究分析了全球骨科生物製品市场，提供市场规模和预测、市场动态、主要参与者状况和前景等。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第四章全球骨科生物製品市场展望（2017-2031）

  • 市场规模与预测
    • 金额
    • 数量
  • 按产品
    • 去矿物质骨基质 (DBM)
    • 关节内补充剂
    • 合成骨替代物
    • 同种异体移植物
    • 骨生长因子
    • 其他
  • 依用途
    • 重建手术/骨折手术
    • 骨关节炎
    • 脊椎固定
    • 软组织修復
    • 颚面/牙科
    • 其他
  • 按最终用户
    • 医院
    • 门诊/创伤照护中心
    • 骨科诊所
    • 牙医诊所/设施
    • 其他
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东/非洲
  • 市占率：依公司划分（2023 年）

第 5 章全球骨科生物製品市场展望：按地区划分（2017-2031 年）

  • 北美
    • 市场规模与预测
    • 按产品
    • 依用途
    • 按最终用户
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 南美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第 6 章市场地图（2023 年）

  • 按产品
  • 依用途
  • 按最终用户
  • 按地区

第七章宏观环境与产业结构

  • 需求与供给分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题、限制因素）

第九章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析（2023 年）
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家公司进入市场）
  • 专利分析（如果适用）

第10章价格分析

第 11 章案例研究

第十二章主要公司展望

  • Stryker Corporation
  • Johnson & Johnson
  • Zimmer Biomet Holdings Inc.
  • Arthrex, Inc.
  • Wright Medical Group N.V.
  • Integra Lifesciences Holdings Corporation
  • Globus Medical Inc.
  • Medline Industries Inc.
  • Bioventus Inc.
  • Exactech Inc.

第 13 章策略建议

第14章关于我们公司，免责声明

Product Code: MX11017

Global orthobiologics market is projected to witness a CAGR of 6.08% during the forecast period 2024-2031, growing from USD 7.01 billion in 2023 to USD 11.24 billion in 2031. The global orthobiologics market is mostly driven by technological improvements. Orthobiologic solutions are now more widely available, thanks to advancements in medical technology, including improved biomaterials and surgical methods. The ability to treat bone and joint problems more effectively is being made possible by this advancement, which makes orthobiologic choices more appealing to patients and physicians alike.

The global orthobiologics market is expanding due to the ageing of the world's population. People who live longer are more likely to experience age-related orthopedic problems like osteoporosis and arthritis. The need for orthobiologic therapies, which are frequently utilized to accelerate the healing process for fractures and degenerative diseases that are widespread among the elderly, is increased by this shift in demography.

The global orthobiologics market is growing due to an increase in orthopedic problems across all age categories, including younger and more active people. An increasing number of patients require orthobiologic therapy due to the rise in musculoskeletal problems and sports-related injuries linked to lifestyle choices.

Furthermore, the dynamics of the global orthobiologics market is influenced by the growing desire for less intrusive surgical solutions. Orthobiologics are frequently utilized in minimally invasive operations; its benefits include shortened recovery times, a lower chance of infection, and decreased postoperative pain. Orthobiologic products are being more widely used in operations, particularly sports medicine surgical procedures, because of the shift towards less intrusive techniques.

Tetrous, Inc., for example, announced in July 2023 the issuance of a U.S. patent for Enfix(TM) Demineralized Bone Fibre Implants for use in sports medicine surgical operations. The first product in the EnFix family, EnFix RC, is an implant designed specifically for rotator cuff repair procedures. Australia and the United States are the only countries where it is now accessible.

Surge in Orthopedic Disorders Boosting the Market

The global orthobiologics market is growing rapidly due to the rising prevalence of orthopedic disorders worldwide. More people are experiencing conditions, including osteoporosis, arthritis, and spinal problems, which increases the demand for efficient treatment solutions. By encouraging bone repair and regeneration, orthobiologics is critical in treating these conditions. The need for these therapies is further increased by the rise in musculoskeletal issues and sports injuries brought on by contemporary lifestyles. The global orthobiologics market is expanding because of the rise in health concerns, which, in turn, is driving research and development efforts to produce more sophisticated and efficacious solutions for various orthopedic problems.

According to a recent study published in 'The Lancet Rheumatology' journal, there will be a 115 percent increase in problems of the joints, muscles, and bones during the next thirty years. By 2050, more than a billion people worldwide will likely be suffering from illnesses of the muscles, bones, joints, ligaments, tendons, and spine-a number that has increased from roughly half a billion in 2020. The impact of the Covid pandemic on our musculoskeletal system may play a significant role in these predictions.

Technological Advancements Fueling the Market

Technological advancements play a major role in the growth of the global orthobiologics market, particularly in the form of new and more effective products and treatment methods. Treatments for problems with the bones and joints are now more successful because of developments in biomaterials and biological therapies. For instance, improvements in tissue engineering and regenerative medicine have raised the calibre of scaffolds and bone transplants that are essential for orthopedic procedures. Advances in 3D printing technology also allow for customized orthopedic devices and implants, made to fit each patient's unique needs. In addition to improving patient outcomes, these technological advancements broaden the range of illnesses that can be treated, which grows the global orthobiologics market.

For instance, leading medical technology business, Xenco Medical showcased its TrabeculeX Continuum at the 2024 Consumer Electronics Show in Las Vegas, Nevada, on January 11th, showing its convergent technology that bridges biomaterials and digital health. The TrabeculeX Continuum, which integrates the TrabeculeX Bioactive Matrix and the TrabeculeX Recovery App, is the first technologically enabled link between digital health and orthobiologics, streamlining a patient's postoperative course and biomaterial implantation.

Growing Demand for Orthobiologics in Spinal Fusion Surgeries

Orthopedics use in spinal fusion procedures is a major driver of the global orthobiologics market. In joining two or more spinal vertebrae, orthobiologic materials, such as demineralized bone matrices, bone transplants, and bone morphogenetic proteins, play a critical role in spinal fusion. They lead to better patient outcomes and healing by dramatically improving the bone development and healing required for a successful fusion. The number of spinal fusion operations rises because of the rising incidence of spinal diseases, which are linked to factors including an aging population and unproductive lifestyles. The increase in surgeries is driving the demand for orthobiologic products, which, in turn, is propelling the growth and development of the global orthobiologics market.

For example, the UK-based orthobiologics company Locate Bio announced in May 2023 that LDGraft had received a breakthrough product classification from the US Food and Drug Administration (FDA). LDGraft is developed for anterior lumbar interbody spinal fusion (ALIF) procedures conducted at one level, from L3 to S1, for patients with degenerative disc disease.

The Growing Popularity of Demineralized Bone Matrix

The global orthobiologics market is growing due to the escalating demand for demineralized bone matrix (DBM). DBM is becoming increasingly well-liked because it works well for various orthopedic procedures, including spinal fusion, bone fractures, and joint reconstructions. DBM is a processed type of allograft bone that keeps growth factors essential for bone regeneration. DBM is becoming more popular due to its ability to stimulate bone growth and to work well with other grafts to enhance results. Thus, the growing demand for DBM in orthopedic surgeries is a major driver for the growth of the global orthobiologics market and illustrates the changing landscape of surgical bone healing techniques.

For instance, the full market release and initial implant of Legacy Demineralized Bone Matrix (DBM), a putty for repairing spaces or gaps in bony defects or traumatic injuries of the spine, pelvis, or extremities, were announced in October 2022 by Orthofix Medical Inc., a multinational medical device company with a focus on spine and orthopedics.

North America Dominates the Market

Numerous important variables are responsible for North America's dominant position in the global orthobiologics market. The area is home to a state-of-the-art healthcare system that stimulates substantial medical research and development, particularly in orthopedics. When combined with a significant investment in healthcare and a dedication to innovation, these features improve its position in the market. Orthobiologic treatments are highly needed due to the high prevalence of orthopedic disorders in North America, which are caused by an ageing population, increasing obesity rates, and lifestyle-related musculoskeletal problems. The strict regulatory environment in the area also guarantees the supply of safe and high-quality orthobiologic products, which propels the growth of the global orthobiologics market.

For example, in August 2022, CGBio, a firm that develops novel synthetic bone grafts, and Orthofix Medical Inc., a multinational medical device company focused on spine and orthopedics, signed a strategic cooperation arrangement. The two businesses collaborated to develop Novosis's recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth materials. They also aim to create other tissue regenerative solutions for the American and Canadian markets.

Future Market Scenario (2024 - 2031F)

The global orthobiologics market is poised for growth, influenced by the aging global population, a rise in orthopedic conditions, and breakthroughs in orthobiologic technologies.

The future of the global orthobiologics market is expected to be shaped by continuous research and development efforts, paving the way for the introduction of innovative and more efficient orthobiologic solutions, including cutting-edge biomaterials and regenerative medicine.

With the improvement of healthcare systems in emerging countries, the adoption of orthobiologic treatments in these areas is expected to rise, significantly contributing to the market's expansion.

Potential changes in government regulations and health insurance reimbursement policies could significantly influence the market, impacting the usage and accessibility of orthobiologic treatments and products.

Key Players Landscape and Outlook

One of the key factors driving the growth of the global orthobiologics market is the current noteworthy rise in mergers and acquisitions (M&A). Larger organisations are acquiring smaller or equivalent businesses through M&A transactions in order to expand their product offerings, break into new markets, and gain access to cutting-edge research and technology. Companies can increase their competitive edge, boost market presence, and achieve cost efficiency through these strategic consolidations. Furthermore, the combination of information and resources encourages creativity, which produces better orthobiologic products. Therefore, M&A activity plays a crucial role in shaping the market environment and promoting a more diverse and technologically advanced orthobiologics industry.

For example, in November 2023, Berkeley Biologics-a fully owned subsidiary of GNI Group-completed the acquisition of Elutia's Orthobiologics business unit for up to $35 million in cash. At closing, Elutia received a $15 million upfront payment, with additional earnout payments of up to $20 million possible over the next five years. Through the acquisition, Elutia hopes to give doctors access to the potency of targeted therapies, along with the advantages of natural biological materials for wound healing.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Orthobiologics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product
    • 4.2.1. Demineralized Bone Matrix (DBM)
    • 4.2.2. Viscosupplements
    • 4.2.3. Synthetic Bone Substitutes
    • 4.2.4. Allografts
    • 4.2.5. Bone Growth Factors
    • 4.2.6. Others
  • 4.3. By Application
    • 4.3.1. Reconstructive & Fracture Surgery
    • 4.3.2. Osteoarthritis & Degenerative Arthritis
    • 4.3.3. Spinal Fusion
    • 4.3.4. Soft Tissue Repair
    • 4.3.5. Maxillofacial & Dental
    • 4.3.6. Others
  • 4.4. By End-user
    • 4.4.1. Hospitals
    • 4.4.2. Ambulatory & Trauma Care Centers
    • 4.4.3. Orthopedic Clinics
    • 4.4.4. Dental Clinics & Facilities
    • 4.4.5. Others
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Orthobiologics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product
      • 5.1.2.1. Demineralized Bone Matrix (DBM)
      • 5.1.2.2. Viscosupplements
      • 5.1.2.3. Synthetic Bone Substitutes
      • 5.1.2.4. Allografts
      • 5.1.2.5. Bone Growth Factors
      • 5.1.2.6. Others
    • 5.1.3. By Application
      • 5.1.3.1. Reconstructive & Fracture Surgery
      • 5.1.3.2. Osteoarthritis & Degenerative Arthritis
      • 5.1.3.3. Spinal Fusion
      • 5.1.3.4. Soft Tissue Repair
      • 5.1.3.5. Maxillofacial & Dental
      • 5.1.3.6. Others
    • 5.1.4. By End-user
      • 5.1.4.1. Hospitals
      • 5.1.4.2. Ambulatory & Trauma Care Centers
      • 5.1.4.3. Orthopedic Clinics
      • 5.1.4.4. Dental Clinics & Facilities
      • 5.1.4.5. Others
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Product
      • 5.1.5.3. Demineralized Bone Matrix (DBM)
      • 5.1.5.4. Viscosupplements
      • 5.1.5.5. Synthetic Bone Substitutes
      • 5.1.5.6. Allografts
      • 5.1.5.7. Bone Growth Factors
      • 5.1.5.8. Others
      • 5.1.5.9. By Application
      • 5.1.5.9.1. Metal-On-Metal
      • 5.1.5.9.2. Metal-On-Polyethylene
      • 5.1.5.9.3. Ceramic-On-Metal
      • 5.1.5.9.4. Ceramic-On-Polyethylene
      • 5.1.5.9.5. Ceramic-On-Ceramic
      • 5.1.5.10. By End-user
      • 5.1.5.10.1. Hospitals & Surgical Centers
      • 5.1.5.10.2. Ambulatory & Trauma Care Centers
      • 5.1.5.10.3. Orthopedic Clinics
      • 5.1.5.10.4. Home Care Settings
      • 5.1.5.10.5. Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Key Players Landscape

  • 9.1. Competition Matrix of Top Five Market Leaders
  • 9.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 9.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 9.4. SWOT Analysis (For Five Market Players)
  • 9.5. Patent Analysis (If Applicable)

10. Pricing Analysis

11. Case Studies

12. Key Players Outlook

  • 12.1. Stryker Corporation
    • 12.1.1. Company Details
    • 12.1.2. Key Management Personnel
    • 12.1.3. Products & Services
    • 12.1.4. Financials (As reported)
    • 12.1.5. Key Market Focus & Geographical Presence
    • 12.1.6. Recent Developments
  • 12.2. Johnson & Johnson
  • 12.3. Zimmer Biomet Holdings Inc.
  • 12.4. Arthrex, Inc.
  • 12.5. Wright Medical Group N.V.
  • 12.6. Integra Lifesciences Holdings Corporation
  • 12.7. Globus Medical Inc.
  • 12.8. Medline Industries Inc.
  • 12.9. Bioventus Inc.
  • 12.10. Exactech Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 3. Global Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Orthobiologics Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 9. North America Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 10. North America Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Orthobiologics Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 15. United States Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 16. United States Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 20. Canada Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 21. Canada Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 25. Mexico Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 26. Mexico Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 30. Europe Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 31. Europe Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Orthobiologics Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 36. Germany Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 37. Germany Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 41. France Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 42. France Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 43. France Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 46. Italy Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 47. Italy Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 51. United Kingdom Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 52. United Kingdom Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 56. Russia Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 57. Russia Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 61. Netherlands Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 62. Netherlands Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 66. Spain Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 67. Spain Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 71. Turkey Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 72. Turkey Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 76. Poland Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 77. Poland Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 81. South America Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 82. South America Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Orthobiologics Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 87. Brazil Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 88. Brazil Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 92. Argentina Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 93. Argentina Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 97. Asia-Pacific Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 98. Asia-Pacific Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Orthobiologics Market Share (%), By Country, 2017-2031F
  • Figure 101. India Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 103. India Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 104. India Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 105. India Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 108. China Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 109. China Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 110. China Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 113. Japan Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 114. Japan Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 118. Australia Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 119. Australia Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 123. Vietnam Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 124. Vietnam Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 128. South Korea Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 129. South Korea Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 133. Indonesia Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 134. Indonesia Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 138. Philippines Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 139. Philippines Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 143. Middle East & Africa Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 144. Middle East & Africa Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Orthobiologics Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 149. Saudi Arabia Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 150. Saudi Arabia Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 154. UAE Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 155. UAE Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Orthobiologics Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Orthobiologics Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 159. South Africa Orthobiologics Market Share (%), By Product, 2017-2031F
  • Figure 160. South Africa Orthobiologics Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Orthobiologics Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023